Project Grant R21HD115981
- This $429,000 federal Project Grant award, funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to investigate the gene and environmental influences on placental angiogenesis and severe fetal growth restriction. The University of Colorado-Denver, the awardee organization, will leverage induced pluripotent stem cell technology to better...
- The University of California, San Diego (UCSD) received a $151,040 Project Grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant, awarded on January 25, 2026, with a completion date of July 31, 2027, supports research to investigate the effects of rare damaging mutations in TGFβ latent complex proteins found in preeclamptic placentas. The key...
- This Project Grant award of $148,880 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to investigate the long-term effects of preeclampsia (PE) on offspring. The research aims to isolate B cells from the placentas of PE patients and transfer them into pregnant rats to examine the impact on blood pressure, immune cells, cerebrovascular function, and cognitive...
- This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $485,925 to the University of Massachusetts Boston to develop novel antioxidant compounds for treating preeclampsia, a life-threatening pregnancy complication. The primary goal is to design and synthesize cationic hydrazone antioxidants that can target mitochondria to reduce oxidative stress, improve...
- This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $678,809 to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to conduct a randomized controlled trial. The study aims to: 1) determine platelet inhibition and factors impacting aspirin response in high-risk pregnant women, 2) establish aspirin pharmacokinetics and...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $2,559,308 to examine the impact of severe pre-eclampsia on heart function in diverse racial groups of women. The project will evaluate heart function at delivery and at 6- and 12-months postpartum, as well as characterize the cardiomyopathic genetic profile of the participants. A sub-award of undisclosed amount has been issued to...
- This $446,000 project grant awarded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to examine the impact of cash transfers during pregnancy on maternal and infant health and health disparities in the US. The project will leverage the 2021 expansion of the US Child Tax Credit as a natural experiment to 1) estimate the impacts of receiving monthly cash...
- This Project Grant award from the Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development provides $769,916 to Emergent Biotechnologies LLC for research into a novel therapy for preeclampsia. The funding supports Phase 1 of developing and characterizing a handle region peptide as an innovative treatment for preeclampsia under the Child Health and Human Development Extramural Research program (CFDA 93.865). Phase 1 work will...
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $446,875 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The grant, awarded on August 15, 2025 with an ultimate completion date of July 31, 2027, will fund the development and evaluation of a "Disparities in Labor...
- The Cooperative Agreement award titled "GESTATIONAL HYPERTENSION AND PREECLAMPSIA BLOOD PRESSURE (BP) TREATMENT GOALS" was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865). The $4,022,302 award, with a performance period from July 1, 2025 to June 30, 2030, supports research initiatives focused on advancing scientific...
The federal Project Grant award, titled "Advancing Health Equity in Preeclampsia Prevention," is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The $431,121 award aims to identify underrepresented racial and ethnic groups with high rates of preeclampsia and model the potential to prevent preeclampsia if they were included in the low-dose aspirin decision algorithm. The objectives are to use hospital discharge data to estimate preeclampsia rates across diverse racial groups and determine which groups have high rates but are underrepresented in the scientific literature. This research seeks to ensure the low-dose aspirin therapy algorithm can be equitably applied to reduce preeclampsia disparities in all pregnant populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/8/25 | ||
| Not listed | $431.1k | 8/4/25 |